April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Intravitreous Heparin-Like Glycosaminoglycan Isolated From a Marine Shrimp Induces Regression of Experimental Choroidal Neovascularization
Author Affiliations & Notes
  • C. V. Regatieri
    Ophthalmology,
    Federal University of Sao Paulo, Sao Paulo, Brazil
  • J. L. Dreyfuss
    Biochemistry,
    Federal University of Sao Paulo, Sao Paulo, Brazil
  • M. A. Lima
    Biochemistry,
    Federal University of Sao Paulo, Sao Paulo, Brazil
  • E. H. Farias
    Biochemistry,
    Federal University of Sao Paulo, Sao Paulo, Brazil
  • A. S. Brito
    Biochemistry, Federal University of Rio Grande do Norte, Natal, Brazil
  • S. F. Chavante
    Biochemistry, Federal University of Rio Grande do Norte, Natal, Brazil
  • H. B. Nader
    Biochemistry,
    Federal University of Sao Paulo, Sao Paulo, Brazil
  • M. E. Farah
    Ophthalmology,
    Federal University of Sao Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  C.V. Regatieri, None; J.L. Dreyfuss, None; M.A. Lima, None; E.H. Farias, None; A.S. Brito, None; S.F. Chavante, None; H.B. Nader, None; M.E. Farah, None.
  • Footnotes
    Support  Brazilian agencies FAPESP, CNPq and CAPES
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3500. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. V. Regatieri, J. L. Dreyfuss, M. A. Lima, E. H. Farias, A. S. Brito, S. F. Chavante, H. B. Nader, M. E. Farah; Intravitreous Heparin-Like Glycosaminoglycan Isolated From a Marine Shrimp Induces Regression of Experimental Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3500.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : It has been shown that a heparin-like glycosaminoglycan obtained from shrimp cephalotorax (Litopenaeus vannamei) is capable to modulate inflammatory responses without interfering on hemostasis. Besides it reduced bleeding potential and anticoagulant activity in vitro, the shrimp heparin-like compound is able to reduce the activity of matrix metalloproteinases, enzymes involved on basal membrane degradation during the angiogenesis process. Thus the objective of this study was to evaluate the effects of this new compound on a laser-induced choroidal neovascularization (CNV) in pigmented Zucker rats and verify the cytotoxicity of this compound in retina pigmented epithelial cells (ARPE-19).

Methods: : Induction of CNV was performed using argon laser. At the end of laser session, saline or heparin-like glycosaminoglycan were injected intravitreously. The animals were divided into 4 groups (laser, and laser with 0.09, 0.9 and 9 µg/mL of heparin-like glycosaminoglycan). After three weeks, the eyes were enucleated and immunofluorescence was performed (flatmount) using anti-von Willebrand factor, a marker for endothelial cells. The cytotoxicity of heparin-like glycosaminoglycan was evaluated by MTT test in ARPE-19 cell culture.

Results: : Immunofluorescence analysis showed significant reduction in CNV lesion area of all groups treated with heparin-like glycosaminoglycan. The regression observed was 28%, 53% and 41% in 0.09, 0.9 and 9 µg/mL treated groups, respectively (P<0.0001). No cytotoxic effect was detected in ARPE-19 cell culture.

Conclusions: : Intravitreal heparin-like glycosaminoglycan from a marine shrimp significantly reduces the CNV lesion area. The optimal dosage to reduce angiogenesis was 0.9 µg/mL and it was non-toxic to the retina pigmented epithelial cells. These results demonstrated a new useful antiangiogenic compound that can be used as a therapy to control choroidal neovascularization.

Keywords: choroid: neovascularization • inflammation • proteoglycans/glycosaminoglycans 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×